Authorities probing ‘counterfeit’ rabies vaccine, says drug regulator
India's drug regulator has opened an investigation into a rabies vaccine suspected of being counterfeit after the Central Drugs Laboratory found that vials marked with batch number KE25012 did not meet potency standards. The vaccine maker has rejected claims that it produced the allegedly misbranded batches, and authorities are continuing to probe the matter for further review.